Aug. 26, 2013
/PRNewswire/ -- Cyberonics, Inc. (NASDAQ:CYBX), a global leader in medical devices for the treatment and management of epilepsy, today announced it will participate in the following conferences.
, Cyberonics' President & Chief Executive Officer, and
, Cyberonics' Corporate Controller, will present at the Morgan Stanley Global Healthcare Conference in
Wednesday, September 11, 2013
9:10 AM Eastern Time
. A live audio webcast of the presentation can be accessed by clicking on the Investor Relations link on the Cyberonics home page at
Mr. Donato will present at the Stifel 2013 Healthcare Conference in
Thursday, September 12, 2013
11:30 AM Eastern Time
. The presentation session will not be webcast.
In addition, Mr. Moore will participate in the 4
Annual Credit Suisse Small & Mid Cap Conference in
Wednesday, September 18, 2013
1:50 PM Eastern Time
. No formal presentation will be made, and the group meeting will not be webcast.
About Cyberonics, Inc. and the VNS Therapy ® System
Cyberonics, Inc. is a medical technology company with core expertise in neuromodulation. The company developed and markets the VNS Therapy System, which is FDA-approved for the treatment of refractory epilepsy and treatment-resistant depression. The VNS Therapy System uses an implanted medical device that delivers pulsed electrical signals to the vagus nerve. Cyberonics markets the VNS Therapy System in selected markets worldwide.
Additional information on Cyberonics and the VNS Therapy System is available at
, CFOCyberonics, Inc.100 Cyberonics Blvd.
77058Main: (281) 228-7262 / Fax: (281) 218-9332
SOURCE Cyberonics, Inc.